FAS-associated factor 1 is a protein that in humans is encoded by the FAF1gene.[1][2]
Interaction of Fas ligand (TNFSF6) with the FAS antigen (TNFRSF6) mediates programmed cell death, also called apoptosis, in a number of organ systems. The protein encoded by this gene binds to FAS antigen and can initiate apoptosis or enhance apoptosis initiated through FAS antigen. Initiation of apoptosis by the protein encoded by this gene requires a ubiquitin-like domain but not the FAS-binding domain.[2]
References
↑Ryu SW, Chae SK, Lee KJ, Kim E (Oct 1999). "Identification and characterization of human Fas associated factor 1, hFAF1". Biochem Biophys Res Commun. 262 (2): 388–94. doi:10.1006/bbrc.1999.1217. PMID10462485.
Juo P, Kuo CJ, Yuan J, Blenis J (1998). "Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade". Curr. Biol. 8 (18): 1001–8. doi:10.1016/S0960-9822(07)00420-4. PMID9740801.
Kusk M, Ahmed R, Thomsen B, et al. (1999). "Interactions of protein kinase CK2beta subunit within the holoenzyme and with other proteins". Mol. Cell. Biochem. 191 (1–2): 51–8. doi:10.1023/A:1006840613986. PMID10094392.
Buchberger A, Howard MJ, Proctor M, Bycroft M (2001). "The UBX domain: a widespread ubiquitin-like module". J. Mol. Biol. 307 (1): 17–24. doi:10.1006/jmbi.2000.4462. PMID11243799.
Jensen HH, Hjerrild M, Guerra B, et al. (2001). "Phosphorylation of the Fas associated factor FAF1 by protein kinase CK2 and identification of serines 289 and 291 as the in vitro phosphorylation sites". Int. J. Biochem. Cell Biol. 33 (6): 577–89. doi:10.1016/S1357-2725(01)00039-5. PMID11378439.
Ryu SW, Kim E (2001). "Apoptosis induced by human Fas-associated factor 1, hFAF1, requires its ubiquitin homologous domain, but not the Fas-binding domain". Biochem. Biophys. Res. Commun. 286 (5): 1027–32. doi:10.1006/bbrc.2001.5505. PMID11527403.
Guerra B, Boldyreff B, Issinger OG (2002). "FAS-associated factor 1 interacts with protein kinase CK2 in vivo upon apoptosis induction". Int. J. Oncol. 19 (6): 1117–26. doi:10.3892/ijo.19.6.1117. PMID11713579.
Imai Y, Nakada A, Hashida R, et al. (2002). "Cloning and characterization of the highly expressed ETEA gene from blood cells of atopic dermatitis patients". Biochem. Biophys. Res. Commun. 297 (5): 1282–90. doi:10.1016/S0006-291X(02)02380-X. PMID12372427.
Ryu SW, Lee SJ, Park MY, et al. (2003). "Fas-associated factor 1, FAF1, is a member of Fas death-inducing signaling complex". J. Biol. Chem. 278 (26): 24003–10. doi:10.1074/jbc.M302200200. PMID12702723.
Olsen BB, Jessen V, Højrup P, et al. (2003). "Protein kinase CK2 phosphorylates the Fas-associated factor FAF1 in vivo and influences its transport into the nucleus". FEBS Lett. 546 (2–3): 218–22. doi:10.1016/S0014-5793(03)00575-1. PMID12832043.
Bjørling-Poulsen M, Seitz G, Guerra B, Issinger OG (2004). "The pro-apoptotic FAS-associated factor 1 is specifically reduced in human gastric carcinomas". Int. J. Oncol. 23 (4): 1015–23. doi:10.3892/ijo.23.4.1015. PMID12963981.
Park MY, Jang HD, Lee SY, et al. (2004). "Fas-associated factor-1 inhibits nuclear factor-kappaB (NF-kappaB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-kappaB". J. Biol. Chem. 279 (4): 2544–9. doi:10.1074/jbc.M304565200. PMID14600157.
Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID14702039.
Stoletov KV, Terman BI (2004). "Bmx is a downstream Rap1 effector in VEGF-induced endothelial cell activation". Biochem. Biophys. Res. Commun. 320 (1): 70–5. doi:10.1016/j.bbrc.2004.05.134. PMID15207703.